Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
Clin Mol Hepatol. 2022;28(1):17-30.   Published online 2021 Jul 20     DOI:
Citations to this article as recorded by Crossref logo
Antiviral Therapy for Chronic Hepatitis B Infection Improves Outcomes After Total Hip Arthroplasty: A Multicenter Retrospective Study
Tao Cheng, Guoyong Li, Huiming Ning, Liang Hao
The Journal of Arthroplasty.2023; 38(2): 300.     CrossRef
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(1): 99.     CrossRef
Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Clinical and Molecular Hepatology.2023; 29(1): 191.     CrossRef
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clinical and Molecular Hepatology.2023; 29(1): 113.     CrossRef
Multitasking Na+/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
Dariusz Zakrzewicz, Joachim Geyer
Biomedicines.2022; 10(1): 196.     CrossRef
Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature
Bushra Tahreem, Ghadir Ali , Haroon Ahmad, Asim Shahzad, Muhammad Khurram, Nabiha Naeem , Aquib Nazar , Muhammad Haris , Hassan ., Shahrukh .
Pakistan BioMedical Journal.2022;[Epub]     CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
Current Status of Drug Therapy for Chronic Hepatitis B
显明 尹
Advances in Clinical Medicine.2022; 12(07): 6196.     CrossRef
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B
Chan‐Young Jung, Hyung Woo Kim, Jung Il Lee, Hyun Woong Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Liver International.2022; 42(11): 2408.     CrossRef
Design, Synthesis and Evaluation of Novel 4‐(4‐Chlorobenzyl)‐6‐methylpyridazin‐3(2 H )‐one Derivatives as Hepatitis B Virus Inhibitors
Oya Unsal Tan, Jan Moncol, David Durantel
ChemistrySelect.2022;[Epub]     CrossRef
Hepatitis B functional cure and immune response
Jia-Rui Zheng, Zi-Long Wang, Bo Feng
Frontiers in Immunology.2022;[Epub]     CrossRef
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
Jae Seung Lee, Tae Seop Lim, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyun Woong Lee, Jung Il Lee, Ja Kyung Kim, In Kyung Min, Beom Kyung Kim
Diagnostics.2022; 13(1): 3.     CrossRef
Critical Updates on Chronic Hepatitis B Virus Infection in 2021
Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine
Cureus.2021;[Epub]     CrossRef